Temporal trends and racial disparities in global prostate cancer prevalence

Canadian Journal of Urology

Volumn 21, Issue 5, 2014, Pages 7496-7506

  Rebbeck, Timothy R ^a   Haas, Gabriel P ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c Astellas Global Medical Affairs   (United States)

Author keywords

Disparities; Pautopsy; Prostate cancer prevalence; Temporal trends

Indexed keywords

AGE; ASIAN CONTINENTAL ANCESTRY GROUP; BLACK PERSON; CAUCASIAN; ETHNOLOGY; HEALTH; HEALTH DISPARITY; HUMAN; INCIDENCE; MALE; PREVALENCE; PROSTATE TUMOR; STATISTICS AND NUMERICAL DATA; TIME;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GLOBAL HEALTH; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MALE; PREVALENCE; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 84910050328     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Muir E. Carcinoma of the prostate. Lancet 1934:668-672.
2. Albarran J, Halle N. Hypertrophie et neoplasies epitheliales de la prostate. Annales des Maladies Org Genitoiun 1898;XVI:797-801.
3. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D: GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 In. Lyon, France: International Agency for Research on Cancer; 2010.
4. SEER: Surveillance, Epidemiology, and End Results (SEER) Program. In.: National Cancer Institute.
5. Howlader N NA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds): SEER Cancer Statistics Review, 1975-2008. In: SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011.
6. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2008.
7. Rebbeck TR, Devesa SS, Chang BL et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer 2013;2013:560857.
8. Etzioni R, Penson DF, Legler JM et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94(13):981-990.
9. Osegbe DN. Prostate cancer in Nigerians: facts and nonfacts. J Urol 1997;157(4):1340-1343.
10. Scott R, Mutchnik DL, Laskowski TZ, Schmalhorst WR. Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J Urol 1969;101(4):602-607.
11. Hirst AE, Bergman RT. Carcinoma of the prostate in men 80 or more years old. Cancer 1954;7(1):136-141.
12. Schütze U. Latent prostatic carcinoma--an autopsy study of men over 50 years of age. Zentralbl Allg Pathol 1984;129(4):357-364.
13. Rothman K, Greenland S, TL L. Modern Epidemiology, Third Edition. Philadelphia: Lippincott, Williams and Wilkins; 2008.
14. Sanchez-Chapado M, Olmedilla G, Cabeza M, Donat E, Ruiz A. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate 2003;54(3):238-247.
15. Stamatiou K, Alevizos A, Perimeni D, Sofras F, Agapitos E. Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study. Prostate Cancer Prostatic Dis 2006;9(1):45-49.
16. Soos G, Tsakiris I, Szanto J, Turzo C, Haas PG, Dezso B. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol 2005;48(5):739-744.
17. Zare-Mirzaie A, Balvayeh P, Imamhadi MA, Lotfi M. The frequency of latent prostate carcinoma in autopsies of over 50 years old males, the Iranian experience. Med J Islam Repub Iran 2012;26(2):73-77.
18. Breslow N, Chan CW, Dhom G et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 1977;20(5): 680-688.
19. Guileyardo JM, Johnson WD, Welsh RA, Akazaki K, Correa P. Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst 1980;65(2):311-316.
20. Sakr WA, Grignon DJ, Crissman JD et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994;8(3):439-443.
21. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000;82(9):1585-1592.
22. Haas GP, Delongchamps NB, Jones RF et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 2007;99(19):1484-1489.
23. Bul M, Delongchamps NB, Steyerberg EW et al. Updating the prostate cancer risk indicator for contemporary biopsy schemes. Can J Urol 2011;18(2):5625-5629.
24. Bjurlin MA, Carter HB, Schellhammer P et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol 2013;189(6):2039-2046.
25. Carter HB, Albertsen PC, Barry MJ et al. Early detection of prostate cancer: AUA Guideline. J Urol 2013;190(2):419-426.
26. Boffetta P, Tubiana M, Hill C et al. The causes of cancer in France. Ann Oncol 2009;20(3):550-555.
27. Thompson IM, Goodman PJ, Tangen CM et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349(3):215-224.
28. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150(2 Pt 1):379-385.
29. Thompson IM, Pauler DK, Goodman PJ et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004;350(22):2239-2246.
30. Bjurlin M, Carter H, Schellhammer P et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol 2013;189(6):2039-2046.
31. Neller V, Neüburger K. Ueber atypische Epithelwucherungen und beginnende Karzinome in der senilen Prostata. 1926;73:57-59.
32. Caulk, Bonn-Itt. Latent prostatic cancer. Am J Cancer 1932;16:1024.
33. Mintz R, Smith G. Autopsy findings in 100 cases of prostatic cancer. N Engl J Med 1934;211(11):479-489.
34. Rich AR. On the frequency of occult carcinoma of the prostate. J Urol 1935;33(3):315-323.
35. Moore R. Latent prostatic cancer. J Urol 1935;33(3):224.
36. Graves R, Militzer R. Carcinoma of the prostate with metastases. J Urol 1935;33(3):235-251.
37. d'Abreu M. Urologie Rev 1936;40:12.
38. Barringer B. Prostate cancer. Am J Roentgenol 1937;37:49.
39. Myers G. Prostate cancer. Colorado Med 1937;34:248.
40. Walthard Z. Prostatenkrebs. Zeitschrift Urol Chir 1931;32:411.
41. Gaynor E. Prostate cancer. Virchows Archive Path Anat 1938;301: 602-656.
42. Yotsuyanagi S. Prostate cancer. Gann 1938;32:191.
43. Kahler J. Prostate cancer. J Urol (Baltimore) 1939;41:557-574.
44. Baron E, Angrist A. Prostate cancer. Arch Pathol 1941;32:787-793.
45. Lowsley O. Surgical and nonsurgical treatment of prostate cancer. Bulletin of the NY Acad Sci 1941:651-673.
46. Butler J, Braunstein H, Freiman DG, Gall EA. Incidence, distribution, and enzymatic activity of carcinoma of the prostate gland. Arch Pathol 1959;68:243-251.
47. Vernet S. Cancer des prostata. Barcelona 1944:17.
48. Buchert WI, Culp DA, Jones GH. Carcinoma of the prostate gland; an analysis of 135 consecutive cases. PA Med J 1947;51(2):165-173.
49. Mathe CP, Ardila CE. Carcinoma of the prostate; review of 130 cases treated between 1940 and 1946. Surg Gynecol Obstet 1947;84(3): 276-282.
50. Meyenburg V. Prostate cancer. Schweiz Med Wochenschrift 1948; 78:473.
51. Andrews GS. Latent carcinoma of the prostate. J Clin Pathol 1949; 2(3):197-208.
52. Horstmann W. Neoplastic diseases of the prostate, especially of the carcinoma. Z Urol 1952;45(1):50-59.
53. Labess M. Occult carcinoma in clinically benign hypertrophy of the prostate; a pathological and clinical study. J Urol 1952;68(6):893-896.
54. Edwards CN, Steinthorsson E, Nicholson D. An autopsy study of latent prostatic cancer. Cancer 1953;6(3):531-554.
55. Franks LM. Latent carcinoma of the prostate. J Pathol Bacteriol 1954;68(2):603-616.
56. Oota K, Misu Y. Gann 1958;49(Suppl):283-284.
57. Viitanen I, Von Hellens A. Latent carcinoma of the prostate in Finland; preliminary report. Acta Pathol Microbiol Scand 1958;44(1): 64-67.
58. Sugihara G. Gann 1959;50(Suppl):163-164.
59. Oota K. Latent carcinoma of the prostate among the Japanese. Acta Un Int Cancer 1961;17:952-957.
60. Karube K. Study of latent carcinoma of the prostate in the Japanese based on necropsy material. Tohoku J Exp Med 1961;74: 265-285.
61. Strahan RW. Carcinoma of the prostate: incidence, origin, pathology. J Urol 1963;89:875-880.
62. Schmalhorst WR, Halpert B. Carcinoma of the prostate gland in patients more than 80 years old. Am J Clin Pathol 1964;42:170-173.
63. Halpert B, Schmalhorst WR. Carcinoma of the prostate in patients 70 to 79 years old. Cancer 1966;19(5):695-698.
64. Halpert B, Sheehan EE, Schmalhorst WR, Scott R. Carcinoma of the prostate. A survey of 5,000 autopsies. Cancer 1963;16:737-742.
65. Liavåg I. The localization of prostatic carcinoma. An autopsy study. Scand J Urol Nephrol 1968;2(2):65-71.
66. Lundberg S, Berge T. Prostatic carcinoma. An autopsy study. Scand J Urol Nephrol 1970;4(2):93-97.
67. Akazaki K, Stemmerman GN. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst 1973;50(5):1137-1144.
68. Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982;29(6):611-616.
69. Yatani R, Shiraishi T, Nakakuki K et al. Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J Natl Cancer Inst 1988;80(9):683-687.
70. Gatling RR. Prostate carcinoma: an autopsy evaluation of the influence of age, tumor grade, and therapy on tumor biology. South Med J 1990;83(7):782-784.
71. Stemmermann GN, Nomura AM, Chyou PH, Yatani R. A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience. Cancer Epidemiol Biomarkers Prev 1992;1(3):189-193.
72. Takahashi S, Shirai T, Hasegawa R, Imaida K, Ito N. Latent prostatic carcinomas found at autopsy in men over 90 years old. Jpn J Clin Oncol 1992;22(2):117-121.
73. Shiraishi T, Watanabe M, Matsuura H, Kusano I, Yatani R, Stemmermann GN. The frequency of latent prostatic carcinoma in young males: the Japanese experience. In Vivo 1994;8(3):445-447.
74. Konety BR, Bird VY, Deorah S, Dahmoush L. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol 2005;174(5): 1785-1788; discussion 1788.
75. Delongchamps NB, Singh A, Haas GP. Epidemiology of prostate cancer in Africa: another step in the understanding of the disease? Curr Probl Cancer 2007;31(3):226-236.
76. Van der Kwast TH, Roobol MJ. Defining the threshold for significant versus insignificant prostate cancer. Nat Rev Urol 2013; 10(8):473-482.